What is NDC 68999-528?

68999-528 is the product NDC for Atovaquone, Atovaquone 750 mg/5mL suspension, listed with the FDA by Chartwell Governmental & Specialty RX, LLC.. It has 1 package NDC, shown above in 10- and 11-digit form.

Chartwell Governmental & Specialty RX, LLC., NDC labeler code 68999. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Atovaquone?

20 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Atovaquone NDC 68999-528 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68999-528Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68999-0528Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68999-528-24	68999052824	2 TRAY in 1 BOX (68999-528-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-528-45)Marketed from Oct 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atovaquone
Generic name (nonproprietary): atovaquone
Active ingredients: Atovaquone — 750 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: Chartwell Governmental & Specialty RX, LLC.NDC labeler code 68999
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207833
Marketing start: Apr 28, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 68999-528_430808cb-6a2f-94ee-e063-6394a90ab6fdSPL ID 430808cb-6a2f-94ee-e063-6394a90ab6fdSPL set ID e6770b85-54f8-4969-af02-7d81586be761RxCUI 308429UNII Y883P1Z2LT
Pharmacologic class: Antimalarial; Antiprotozoal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468999052824 followed by a unit qualifier and the quantity

Package 68999-0528-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 7, 2025.

Indications (excerpt from the label)

Atovaquone oral suspension is a quinone antimicrobial drug indicated for: Prevention of Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprimsulfamethoxazole (TMP-SMX). ( 1.1 ) Treatment of mild-to-moderate PCP in adults and adolescents aged 13 years and older who cannot tolerate TMP-SMX. ( 1.2 ) Limitations of Use ( 1.3 ) : Treatment of severe PCP (alveolar arterial oxygen diffusion gradient [(Aa) DO 2 ] >45 mm Hg) with atovaquone oral suspension has not been studied. The efficacy of atovaquone oral suspension in subjects who are failing therapy with TMPSMX has also not been studied. 1.1 Prevention of Pneumocystis jirovecii…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68999-528

What is NDC 68999-528?: 68999-528 is the product NDC for Atovaquone, Atovaquone 750 mg/5mL suspension, listed with the FDA by Chartwell Governmental & Specialty RX, LLC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Atovaquone.
What is the active ingredient?: Atovaquone.
Who is the labeler?: Chartwell Governmental & Specialty RX, LLC., NDC labeler code 68999. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Atovaquone?: 20 other product NDCs are listed under this name. See all Atovaquone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Atovaquone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	AvKARE	73190-098	73190-0098-21
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	AvPAK	50268-119	50268-0119-12
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	PAI Holdings, LLC dba PAI Pharma	0121-0956	00121-0956-08
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	A2A Integrated Pharmaceuticals, LLC	73141-104	73141-0104-42
Atovaquoneatovaquone oral suspension	Atovaquone 750 mg/5mL	SuspensionOral	Major Pharmaceuticals	0904-7459	00904-7459-2500904-7459-53
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Kesin Pharma	81033-104	81033-0104-2281033-0104-4281033-0104-50
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	NorthStar RxLLC	72603-248	72603-0248-01
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	PAI Holdings, LLC dba PAI Pharma	0121-1016	00121-1016-1800121-1016-42
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Abon Pharmaceuticals, LLC	42239-001	42239-0001-0842239-0001-66
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Bionpharma Inc.	69452-252	69452-0252-87

All 21 Atovaquone NDCs

Other NDCs under ANDA 207833

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207833
Product	Strength	Form · route	Labeler	Product NDC
Atovaquone	Atovaquone 750 mg/5mL	SuspensionOral	Chartwell RX, LLC	62135-528